Literature DB >> 2598483

The prevention of thalassemia in Sardinia.

A Cao1, C Rosatelli, R Galanello, G Monni, G Olla, P Cossu, M S Ristaldi.   

Abstract

In this paper we review the characteristics and effectiveness of a program aimed at preventing homozygous beta-thalassemia in the Sardinian population. The target population for screening were couples at marriage, conception or early pregnancy. Awareness of the problem and the involvement of the population were achieved via the mass media or by personal approaches through lectures or discussions. Parents' Associations were consulted and have made themselves available to prospective couples in several critical areas. Education on thalassemias was introduced into the school curriculum. Counseling was based on private interviews at which the several options available were discussed with the individual carrier or the couples. Prenatal diagnosis was chosen by the large majority of couples counseled. The introduction of 1st trimester diagnosis resulted in a striking increase of the acceptance rate from 93.2 to 99.1%. Prenatal diagnosis was carried out initially by fetal blood analysis and thereafter by trophoblast or amniocyte DNA analysis. Direct detection of the mutation by oligonucleotide hybridization on agarose gel separated DNA fragments or by dot-blot analysis with allelic specific oligonucleotide probes on enzymatically amplified DNA was used. This program resulted in a decline in thalassemia major births of 90%. The reasons for residual cases were mostly lack of information and, less frequently, misdiagnoses or refusal of fetal diagnosis.

Entities:  

Mesh:

Year:  1989        PMID: 2598483

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Eugenics and the misuse of genetic information to restrict reproductive freedom: ASHG statement.

Authors: 
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

2.  A comparison of two approaches to education about carrier testing for cystic fibrosis.

Authors:  K P Leonard; L K Bartholomew; P R Swank; G S Parcel
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

3.  The thalassemias and health care in Canada: a place for genetics in medicine.

Authors:  D H Chui; S C Wong; C R Scriver
Journal:  CMAJ       Date:  1991-01-01       Impact factor: 8.262

4.  Comparing knowledge of beta-thalassemia in samples of Italians, Italian-Americans, and non-Italian-Americans.

Authors:  Christina Armeli; Steven J Robbins; Deborah Eunpu
Journal:  J Genet Couns       Date:  2005-10       Impact factor: 2.537

Review 5.  Population programs for the detection of couples at risk for severe monogenic genetic diseases.

Authors:  Joël Zlotogora
Journal:  Hum Genet       Date:  2009-04-24       Impact factor: 4.132

6.  Prevention of β Thalassemia in Northern Israel - a Cost-Benefit Analysis.

Authors:  Ariel Koren; Lora Profeta; Luci Zalman; Haya Palmor; Carina Levin; Ronit Bril Zamir; Stavit Shalev; Orna Blondheim
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-17       Impact factor: 2.576

Review 7.  From Prenatal to Preimplantation Genetic Diagnosis of β-Thalassemia. Prevention Model in 8748 Cases: 40 Years of Single Center Experience.

Authors:  Giovanni Monni; Cristina Peddes; Ambra Iuculano; Rosa Maria Ibba
Journal:  J Clin Med       Date:  2018-02-20       Impact factor: 4.241

8.  Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.

Authors:  Mohamed Bejaoui; Naouel Guirat
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.